USA Freedom Act

USA Freedom Act Security Policies Bundle 2022: The Tools you Need to Comply with the USA Freedom Act and to Protect your Most Valuable Assets

Retrieved on: 
Friday, December 9, 2022

DUBLIN, Dec. 9, 2022 /PRNewswire/ -- The "USA Freedom Act Security Bundle" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 9, 2022 /PRNewswire/ -- The "USA Freedom Act Security Bundle" report has been added to ResearchAndMarkets.com's offering.
  • At the same time this has put the onus on US corporations to comply with the mandates of the law.
  • The USA Freedom Act Security Bundle has been updated to reflect all of the legislation that has be enacted by the US Congress.
  • Policies included in the USA Freedom Act Security Bundle are:
    The USA Freedom Act Security Bundle contains the tools you need to comply with the USA Freedom Act and to protect your most valuable assets.

USA Freedom Act Security Policies Bundle 2022: New Mandates on How Corporations Collect, Process, and Store Data - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022

The USA Freedom Act places new mandates on how corporations collect, process, and store data and at the same time allows investigators to use the tools that were already available under the USA Patriot Act to monitor the flow and retrieval of data.

Key Points: 
  • The USA Freedom Act places new mandates on how corporations collect, process, and store data and at the same time allows investigators to use the tools that were already available under the USA Patriot Act to monitor the flow and retrieval of data.
  • At the same time this has put the onus on US corporations to comply with the mandates of the law.
  • The USA Freedom Act Security Bundle has been updated to reflect all of the legislation that has be enacted by the US Congress.
  • Policies included in the USA Freedom Act Security Bundle are:
    The USA Freedom Act Security Bundle contains the tools you need to comply with the USA Freedom Act and to protect your most valuable assets.

Silence Therapeutics Announces SLN360 Phase 1 Data Accepted for Late-Breaking Presentation at the American College of Cardiology (ACC) Annual Scientific Session and Expo

Retrieved on: 
Wednesday, January 26, 2022

Silence remains on-track to report topline data from the SLN360 phase 1 study via press release this quarter.

Key Points: 
  • Silence remains on-track to report topline data from the SLN360 phase 1 study via press release this quarter.
  • Detailed results from the SLN360 phase 1 single-ascending dose study (APOLLO Trial) will be presented by principal investigator, Steven E. Nissen, MD, at the ACC meeting on April 3, 2022.
  • Silence also maintains ongoing research and development collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals, and Hansoh Pharma, among others.
  • Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements.